Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00261742Phase 4Terminated
Phase 4, randomised, open-label trial of cefuroxime in perianal dermatitis, sponsored by University Children's Hospital Basel. Primary endpoint: Resolving signs and symptoms of perianal dermatitis at Day 10. Started Oct 2005; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00261742.